IMMUNOMEDICS' EUROPEAN PATENT SUCCESSFULLY OPPOSED
IMMUNOMEDICS' EUROPEAN PATENT SUCCESSFULLY OPPOSED WARREN, N.J., May 5 /PRNewswire/ -- Immunomedics, Inc.
(NASDAQ: IMMU) announced today that the European Patent Office reversed the prior validation of Immunomedics' patent covering monoclonal antibody fragments used in cancer imaging. In April 1990, the company's patent (EP 35,265) was upheld in an administrative proceeding before the European Patent Office. Corresponding patents issued in the United States, Canada, and certain other countries are not affected by this ruling nor is Immunomedics' right to sell products in Europe influenced by this ruling. While, on the basis of the ruling, the company cannot currently prevent other companies from entering the European market, Immunomedics has various other patents pending in the European Patent Office covering its broad product portfolio in clinical trials and certain products of competitors. These patents include direct labeling of antibodies with technetium and rhenium and certain anti-cancer antibodies. The ruling also does not affect any of these pending patents.
"This decision was based upon 'prior art' which is not applicable in the U.S. and Canada due to differing patent laws. Consequently, we are confident in the strength of our issued patents in these countries," stated Gilbert W. Rudman, company patent counsel. Immunomedics is a biopharmaceutical company applying innovative technology in antibody selection, modification and chemistry to the development of products for the detection and treatment of cancers and infectious diseases. Integral to these products are highly specific monoclonal antibodies designed to deliver radioisotopes, chemotherapeutic agents or toxins to tumors and sites of infections or other diseases. -0- 5/5/92 /CONTACT: Amy Factor of Immunomedics, 908-647-5400/ CO: Immunomedics, Inc. ST: New Jersey IN: MTC SU:
PS-SH -- NY096 -- 6797 05/05/92 17:33 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||May 5, 1992|
|Previous Article:||PRAIRIE OIL ROYALTIES COMPANY LTD. ANNOUNCES FIRST QUARTER RESULTS|
|Next Article:||TREADCO, INC. ANNOUNCES 1992 SECOND QUARTER CASH DIVIDEND|